Switch to
View more

Indoco Remedies Ltd

INDOCO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,387 cr, stock is ranked 569
Moderate RiskStock is 2.27x as volatile as Nifty
370.152.55 (+0.69%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,387 cr, stock is ranked 569
Moderate RiskStock is 2.27x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
21.88
PB RatioPB Ratio
4.41
Dividend YieldDiv. Yield
0.61%
Sector PESector PE
32.93
Sector PBSector PB
4.55
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

86%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Indoco Remedies Limited is engaged in the manufacture of pharmaceutical products. The Company primarily manufactures and markets Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20192020202120220.971.111.241.54-0.000.020.090.15
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Closure of trading window 
Announced OnJun 30, 2022

Indoco Remedies Limited has informed the Exchange about Closure of trading window | Download

Indoco Remedies Limited has informed the Exchange about Closure of trading window | Download

Disclosure under SEBI Takeover Regulations 
Announced OnJun 18, 2022

Disclosure under Regulation 29 under SEBI (SAST) Regulations, 2011 has been submitted. | Download

Disclosure under Regulation 29 under SEBI (SAST) Regulations, 2011 has been submitted. | Download

Cash Dividend 
Ex. DateSep 17, 2021

Final • Div/Share: ₹ 1.5

See all events